Cinatl, Jindrich
Cinatl, Jindrich, 19..-....
Činátl, Jindřich, jr., 1958-
Jindřich Činátl Narozen 1958. Prof. MUDr., virolog, onkolog, dětský onkolog, působí v Německu (Institut für Medizinische Virologie, Klinikum der J. W. Goethe-Universität, Frankfurt am Main, Německo; Klinika dětské hematologie a onkologie, 2. lékařská fakulta, Univer
VIAF ID: 30260009 (Personal)
Permalink: http://viaf.org/viaf/30260009
Preferred Forms
- 200 _ | ‡a Cinatl ‡b Jindrich
-
- 100 1 _ ‡a Cinatl, Jindrich
-
- 100 1 _ ‡a Cinatl, Jindrich
- 100 1 _ ‡a Cinatl, Jindrich
- 100 1 _ ‡a Cinatl, Jindrich (sparse)
- 100 | _ ‡a Cinatl, Jindrich, ‡d 19..-....
- 100 0 _ ‡a Jindřich Činátl ‡c Narozen 1958. Prof. MUDr., virolog, onkolog, dětský onkolog, působí v Německu (Institut für Medizinische Virologie, Klinikum der J. W. Goethe-Universität, Frankfurt am Main, Německo; Klinika dětské hematologie a onkologie, 2. lékařská fakulta, Univer
-
4xx's: Alternate Name Forms (5)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies | |
CD47 as a potential biomarker for the early diagnosis of severe COVID-19 | |
Characterization of ACE inhibitors and AT1R antagonists with regard to their effect on ACE2 expression and infection with SARS-CoV-2 using a Caco-2 cell model | |
Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine | |
Chemoresistance is associated with increased cytoprotective autophagy and diminished apoptosis in bladder cancer cells treated with the BH3 mimetic (-)-Gossypol (AT-101) | |
Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest | |
Constitutive Cell Proliferation Regulating Inhibitor of Protein Phosphatase 2A (CIP2A) Mediates Drug Resistance to Erlotinib in an EGFR Activating Mutated NSCLC Cell Line | |
Correlation of inflammatory and proangiogenic cytokines from undiluted vitreous samples with spectral domain OCT scans, in untreated branch retinal vein occlusion | |
COVID-19 PHARMACOME: a method for the rational selection of drug repurposing candidates from multimodal knowledge harmonization | |
COVID-19-related coagulopathy - is transferrin a missing link? | |
Development and optimization of a high-throughput screening assay for in vitro anti-SARS-CoV-2 activity: Evaluation of 5676 Phase 1 Passed Structures | |
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells | |
Drug-resistant urothelial cancer cell lines display diverse sensitivity profiles to potential second-line therapeutics | |
Electrochemical determination of enzymes metabolizing ellipticine in thyroid cancer cells - a tool to explain the mechanism of ellipticine toxicity to these cells | |
Enisamium inhibits SARS-CoV-2 RNA synthesis | |
Entwicklung von Zellkulturen in proteinfreien chemisch volldefinierten Medien Perspektiven für die Virologie und Biotechnologie | |
Enzastaurin inhibits ABCB1-mediated drug efflux independently of effects on protein kinase C signalling and the cellular p53 status | |
Etablierung eines Modells mit lentiviralen Vektoren zur Untersuchung der onkomodulatorischen Effekte der immediate-early-Proteine IE1 und IE2 des humanen Cytomegalovirus | |
Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings | |
Gene expression signature of acquired chemoresistance in neuroblastoma cells | |
Genome-scale integration of transcriptome and metabolome unveils squalene synthase and dihydrofolate reductase as targets against AML cells resistant to chemotherapy | |
Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression | |
Growth factor receptor signaling inhibition prevents SARS-CoV-2 replication | |
Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells | |
Human cytomegalovirus infection alters PC3 prostate carcinoma cell adhesion to endothelial cells, extracellular matrix | |
Human cytomegalovirus infection of tumor cells downregulates NCAM (CD56): a novel mechanism for virus-induced tumor invasiveness | |
Human mesenchymal stromal cells are resistant to SARS-CoV-2 infection under steady-state, inflammatory conditions and in the presence of SARS-CoV-2-infected cells | |
Human neuroblastoma cells with acquired resistance to the p53 activator RITA retain functional p53 and sensitivity to other p53 activating agents | |
Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform | |
Identification of Z-Tyr-Ala-CHN2, a cathepsin L inhibitor with broad-spectrum cell-specific activity against coronaviruses, including SARS-CoV-2 | |
Impact of the COVID-19 pandemic on the circulation of other pathogens in England | |
In vitro activity of itraconazole against SARS-CoV-2 | |
In vitro Charakterisierung von Cisplatin-resistenten Neuroblastom-Sublinien | |
In-Vitro- und in-Vivo-Modelluntersuchungen zum Immunpathomechanismus der Cytomegalievirus-Infektion beim Menschen | |
Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activity | |
Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants | |
Infectivity of deceased COVID-19 patients | |
Inhibition of apoptosis prevents West Nile virus induced cell death | |
Intact-cell maldi-tof mass spectrometry for the authentication of drug-adapted cancer cell lines | |
Isolation, characterization, differentiation and immunomodulatory capacity of mesenchymal stromal/stem cells from human perirenal adipose tissue | |
Key players of cisplatin resistance towards a systems pharmacology approach | |
Multifaceted roles of SAMHD1 in cancer | |
Multimutated herpes simplex virus G207 is a potent inhibitor of angiogenesis | |
Nano-coating protects biofunctional materials | |
New aspects of CMV-related immunopathology | |
Non-phosphorylatable PEA-15 sensitises SKOV-3 ovarian cancer cells to cisplatin | |
Omeprazole increases the efficacy of acyclovir against herpes simplex virus type 1 and 2 | |
Omicron-induced interferon signalling prevents influenza A virus infection | |
Oncolytic effects of a novel Influenza A virus expressing Interleukin-15 from the NS reading frame | |
Optimized qRT-PCR approach for the detection of intra- abd extra-cellular SARS-CoV-2 RNAs | |
Primary cilia mediate diverse kinase inhibitor resistance mechanisms in cancer | |
Prions, 2000: | |
Prions : a challenge for science, medicine and public health system | |
Regulation der 5-Lipoxygenase durch humane Cytomegalovirus-Infektion | |
Repurposing of the antibiotic nitroxoline for the treatment of mpox | |
Resistance to cytarabine induces the up-regulation of NKG2D ligands and enhances natural killer cell lysis of leukemic cells | |
Rolle retinaler Perizyten nach einer Infektion mit dem Humanen Zytomegalievirus und deren mögliche Bedeutung für eine HCMV-Retinitis | |
routine use of LCD-Array hybridisation technique for HPV subtyping in the diagnosis of penile carcinoma compared to other methods | |
SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabine | |
SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles | |
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment | |
SARS-CoV-2 variants show different host cell proteome profiles with delayed immune response activation in Omicron-infected cells | |
Selection of a highly invasive neuroblastoma cell population through long-term human cytomegalovirus infection | |
Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML | |
Shikonin reduces growth of docetaxel-resistant prostate cancer cells mainly through necroptosis | |
Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1 | |
small molecule inhibitor YK-4-279 disrupts mitotic progression of neuroblastoma cells, overcomes drug resistance and synergizes with inhibitors of mitosis | |
story of human cytomegalovirus and cancer: increasing evidence and open questions | |
Substrate-specific effects of pirinixic acid derivatives on ABCB1-mediated drug transport | |
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants | |
Targeting the pentose phosphate pathway for SARS-CoV-2 therapy | |
Testing of the survivin suppressant YM155 in a large panel of drug-resistant neuroblastoma cell lines | |
thrombopoietin receptor agonist eltrombopag inhibits human cytomegalovirus replication via iron chelation | |
TP53 mutations and drug sensitivity in acute myeloid leukaemia cells with acquired MDM2 inhibitor resistance | |
Tumor-endothelium cross talk blocks recruitment of neutrophils to endothelial cells: a novel mechanism of endothelial cell anergy | |
Überwindung der ABC-Transporter-vermittelten Chemoresistenz in Neuroblastomzellen | |
Untersuchung synthetischer Letalität in Vincristin-resistenten Neuroblastomzellen | |
USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING | |
Virusbedingte Infektionsgefahren in transfusionsmedizinischen und biotechnologischen Arzneimitteln virologische Aspekte und Modelluntersuchungen | |
YM155-adapted cancer cell lines reveal drug-induced heterogeneity and enable the identification of biomarker candidates for the acquired resistance setting |